Cellivery Therapeutics, Inc.

KOSDAQ:A268600 Stock Report

Market Cap: ₩244.9b

Cellivery Therapeutics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Daewoong Jo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership13.9%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates


CEO

Daewoong Jo

no data

Tenure

Dr. Daewoong Jo Ph.D. is the Chief Executive Officer at ProCell Therapeutics Inc.